Monday, 21 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Deals
Biointron Raises USD 72M in Series B to Expand CRO Services and Antibody Platform
February 11, 2025
Company
Simcere Pharma’s H1 2022 Revenue Rises 27% on New Drug Sales, R&D Push
February 11, 2025
Company
Alphamab Oncology Reports H1 2022 Revenue Growth Driven by Envafolimab Commercialization
February 11, 2025
Company
Drug
Akeso Bio’s AK112 Wins Breakthrough Designation for First-Line NSCLC
February 11, 2025
Company
RemeGen’s H1 2022 Revenue Soars 1,094% on Aidixi, Taiai Sales
February 11, 2025
1
2
…
18
19
20
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
